Exhibit 16
Partnership of:
▇▇▇▇ ▇▇▇▇▇▇▇▇ ▇▇▇▇▇▇ ▇. ▇▇▇▇▇▇▇, Inc. ▇▇▇▇▇ ▇. ▇▇▇▇-▇▇▇▇▇▇, Ltd.
▇▇▇▇-▇▇▇▇▇▇ ▇▇▇▇▇▇▇ ▇▇▇▇▇ ▇. ▇▇▇▇, Ltd. ▇▇▇▇▇ ▇. ▇▇▇▇▇▇▇▇▇, Inc.
▇▇▇▇▇▇▇ ▇. ▇▇▇▇▇▇▇▇, Inc. ▇▇▇▇▇▇▇▇ ▇. ▇▇▇▇▇▇▇, Ltd.
Chartered Accountants ▇▇▇▇▇▇ ▇. ▇▇▇▇▇▇▇▇, Inc. Fraser ▇. ▇▇▇▇, Ltd.
▇▇▇▇▇ ▇. ▇▇▇▇, Inc. ▇▇▇▇▇▇▇ ▇. Soda, Inc.
--------------------------------------------------------------------------------
February 6, 2006
Office of the Chief Accountant
Securities and Exchange Commission
▇▇▇ ▇▇▇▇▇ ▇▇▇▇▇▇, ▇.▇.
▇▇▇▇▇▇▇▇▇▇, ▇.▇. ▇▇▇▇▇
Dear Sir or Madam:
We have read the statements about our firm included under Item 4.01 in the
current report on Form 8K/A, dated February 6, 2006, of Neuro-Hitech
Pharmaceuticals, Inc. to be filed with the Securities and Exchange Commission
and are in agreement with the statements contained therein.
Yours truly,
"▇▇▇▇ ▇▇▇▇▇▇▇▇ ▇▇▇▇-▇▇▇▇▇▇ ▇▇▇▇▇▇▇"
▇▇▇▇ ▇▇▇▇▇▇▇▇ ▇▇▇▇-▇▇▇▇▇▇ ▇▇▇▇▇▇▇
CHARTERED ACCOUNTANTS